- Home
- AARD vs GF Comparison
AARD vs GF Comparison
Compare AARD & GF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | AARD | GF |
|---|---|---|
| Founded | 2017 | 1990 |
| Country | United States | Germany |
| Employees | 40 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 165.8M | 183.9M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | AARD | GF |
|---|---|---|
| Price | $6.35 | $11.46 |
| Analyst Decision | Buy | |
| Analyst Count | 9 | 0 |
| Target Price | ★ $15.29 | N/A |
| AVG Volume (30 Days) | ★ 439.3K | 24.0K |
| Earning Date | 05-14-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 0.82% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $3.35 | $9.98 |
| 52 Week High | $17.94 | $12.82 |
Technical Indicators
Market Signals| Indicator | AARD | GF |
|---|---|---|
| Relative Strength Index (RSI) | 58.05 | 45.18 |
| Support Level | $4.76 | $11.21 |
| Resistance Level | $11.37 | $11.52 |
| Average True Range (ATR) | 0.93 | 0.28 |
| MACD | 0.12 | -0.00 |
| Stochastic Oscillator | 52.06 | 29.62 |
Price Performance
Historical ComparisonAbout AARD Aardvark Therapeutics Inc.
Aardvark Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases. It is focused on on developing selective compounds, targeting Bitter Taste Receptors (TAS2Rs) for hunger-associated conditions. Its product candidate, ARD-101, is an oral gut-restricted small-molecule agonist of certain TAS2Rs expressed in the gut lumen for which have initiated a Phase 3 clinical trial for hyperphagia associated with PWS.
About GF New Germany Fund Inc. (The)
NEW GERMANY FUND INC is a non-diversified, closed-end management investment company. As the investment objective, the fund seeks long-term capital appreciation through investment in middle-market German equities. The fund's portfolio of investments includes investments in different sectors such as the industrials, information technology, materials, consumer discretionary, Communication Services, Financials, Consumer Staples, Real Estate, Utilities, Healthcare, Energy, and others. Its portfolio is geographically diversified across the Netherlands, Germany, and Luxembourg.